Charles Bonapace

US Food and Drug Administration

Dr. Charles Bonapace is the Director of the Division of New Drug Bioequivalence Evaluation (DNDBE) in the Office of Study Integrity and Surveillance (OSIS), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA). As the Director, he is responsible for the Good Laboratory Practice (GLP) program and shares the responsibility of the Bioequivalence (BE) program, which includes inspections of GLP and BE testing facilities, and communicating the findings and recommendations to the CDER Offices of New Drugs and Generic Drugs. Prior to joining the FDA, Dr. Bonapace received his BA in Biology from the University of Rochester in Rochester, NY, Doctor of Pharmacy from the University of Maryland in Baltimore, MD, and completed a three-year post-doctoral fellowship in anti-infective pharmacokinetics and pharmacodynamics at the Medical university of South Carolina in
Charleston, SC.

South African National Accreditation System ©2019. ALL RIGHTS RESERVED.